Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
Columbia's Wendy Chung, the original plaintiff in the case against Myriad Genetics, says the Supreme Court decision banning gene patents will open a new era of genomic medicine.
Dr. Ravi P. Kiran has been named chief and program director of the Division of Colorectal Surgery at NewYork-Presbyterian/Columbia University Medical Center.
A study from Columbia University’s Mailman School of Public Health is one of the first assessments of the link between obesity and precancerous abnormalities in biopsy tissue samples.